Tuesday, March 11, 2025 | 12:15 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Vivimed secures additional investment of USD 7.5 mn in its overseas subsidiary

Image

Capital Market

From OrbiMed Asia

Vivimed Labs has signed definitive agreements and received funds to facilitate additional investment of USD 7.5 million (follow on of USD 42.5 million invested in September 2017) by OrbiMed Asia into the Company's subsidiary Vivimed Labs (Mascarene), the holding entitiy of the Company's API business.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 01 2018 | 9:52 AM IST

Explore News